vimarsana.com

மரபியல் உயிரி தொழில்நுட்பவியல் நிறுவனங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Momentum Investing Is Back Don t Miss the Train

January 19, 2021 The thematic space is growing as more ETF providers look to slice and dice into the most profitable business sectors. Global X offers a robust suite of these thematic ETFs. Here are five of their funds that are seeing strong momentum. ETF Database’s intuitive ETF screening tool reveals five funds with a high relative strength index (RSI), indicating investing momentum: Global X Thematic Growth ETF (GXTG): GXTG seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Thematic Growth Index. The fund invests at least 80% of its total assets in the securities of the underlying index.

Can Global X s GNOM Be the Next Big ETF?

Genomics could be the next big thing in the biotechnology space. Similarly, the Global X Genomics & Biotechnology ETF (GNOM) could be the next big fund, and is already up 10% to start the new year. GNOM seeks to provide investment results that correspond generally to the price and yield performance of the Solactive Genomics Index that is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, “Genomics & Biotechnology Companies”), as defined by Solactive AG, the provider of the underlying index. GNOM gives investors:

Get On Board a Growing Biotech Industry With the GNOM ETF

Get On Board a Growing Biotech Industry With the GNOM ETF December 23, 2020 It’s one thing to discuss the economics of investing in the biotech sector, but it’s another to discuss genomics. The sub-sector of the biotech industry has seen strong growth as evidenced by the over 60% gain year-to-date for the GNOM seeks to provide investment results that correspond generally to the price and yield performance of the Solactive Genomics Index that is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, “Genomics & Biotechnology Companies”), as defined by Solactive AG, the provider of the underlying index.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.